Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filing Details

Document Details

Form
Filing Date
Aug 13, 2018
Document Date
Aug 13, 2018
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
electroCore
Issuer
ElectroCore, LL